Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2025-12-17 @ 5:11 PM
Study NCT ID:
NCT06207045
Status:
None
Last Update Posted:
2024-01-16 00:00:00
First Post:
2024-01-05 00:00:00
Brief Title:
The Effects of Limb Elevation During Gout Flare Episodes
Sponsor:
Thammasat University
Organization:
Thammasat University
Study Overview
Official Title:
The Effects of Limb Elevation During Gout Flare Episodes : A Pilot, Randomised Controlled Trial
Status:
None
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Limb elevation has shown benefit in ankle sprain and venous insufficiency, but its benefit has not been studied in people with gout flare. In this open-label randomized controlled trial, 30 adults diagnosed with gout flare during their hospitalization will be randomized to receive limb elevation plus standard medication for gout flare (limb elevation group) or standard medication only (control group). Primary outcome is reduction in 10-point visual analogue scale for pain at 48 hours after enrollment and the secondary outcome is the reduction of the circumference of affected joint at 48 hours after enrollment. Comparison of pain score and joint circumference reduction will be made using Wilcoxon Rank-sum test. Our study results may provide some evidence in support of limb elevation as a supplementary non-pharmacological therapy for relief of gout flare.
Detailed Description:
Limb elevation has shown benefit in ankle sprain and venous insufficiency but its benefit has not been studied in people with gout flare In this open-label randomized controlled trial 30 adults diagnosed with gout flare during their hospitalization will be randomized to receive limb elevation plus standard medication for gout flare limb elevation group or standard medication only control group Primary outcome is reduction in 10-point visual analogue scale for pain at 48 hours after enrollment and the secondary outcome is the reduction of the circumference of affected joint at 48 hours after enrollment Comparison of pain score and joint circumference reduction will be made using Wilcoxon Rank-sum test Our study results may provide some evidence in support of limb elevation as a supplementary non-pharmacological therapy for relief of gout flare
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None